In both patients cohorts, dual nuclear positivity for γH2AX and 8-OHdG identified a MYC/BCL-2 mRNA Double Expresser (DE)-DLBCL subset characterized by dismal outcome (hereafter defined as DE-OX_high) (Fig. 2 C, D). The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.